Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
205.00    -5.00 (-2.38%)
Bid:
204.50
Ask:
205.50
Spread: 1.00 (0.489%)
Market Cap: £545.69m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

£20m Share Buyback Programme

10 Mar 2026 07:01

RNS Number : 9454V
Costain Group PLC
10 March 2026
 

 

10 March 2026

On-market Share Buyback Programme of £20m

 

Costain Group PLC ("Costain" or the "Group") today announces the launch of an on-market share buyback programme (the "Buyback") for a maximum aggregate consideration of £20m.

This follows the intention set out in the announcement dated 26 January 2026, which provided an update on the Group's new pension scheme agreement, enhanced shareholder returns and FY 25 trading. The removal of the dividend parity arrangement, as announced in the update, removed a significant constraint that was on Costain in respect of returns to shareholders.

Having considered the new agreement, the Group's cash performance and ongoing capital requirements, the Board has concluded that an on-market share buyback programme for a maximum aggregate consideration of £20m (excluding stamp duty and expenses) is an appropriate and value-enhancing use of cash, while maintaining the Group's financial flexibility to continue to invest in its strategy to deliver sustainable growth and attractive returns.

Any ordinary shares purchased by the Company will be cancelled and, accordingly, the Buyback will reduce the Company's share capital.

Details of the Buyback

Costain has instructed Panmure Liberum Limited ("Panmure Liberum") and Investec Bank plc ("Investec") to execute the Buyback. Costain has entered into a non-discretionary and irrevocable instruction with Panmure Liberum and Investec, pursuant to which Panmure Liberum (in respect of the First Tranche) and Investec (in respect of the Second Tranche) will each purchase the Company's ordinary shares of 1 pence each ("Ordinary Shares") for up to a maximum consideration of £10m for each tranche, each acting severally as riskless principal. The First Tranche will commence immediately. The Second Tranche will commence following completion of the First Tranche and it is anticipated it will end no later than 31 December 2026, subject to market conditions.

The maximum number of Ordinary Shares that can be purchased in aggregate under the First Tranche and Second Tranche is 20,481,508, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2025 annual general meeting (the "2025 AGM") and any subsequent authority.

Panmure Liberum and Investec will make their trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company, within the terms and pre-set parameters of the Buyback.

Any purchase of Ordinary Shares under the Buyback will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The Buyback will be effected under the general authority to repurchase Ordinary Shares granted by the Company's shareholders at the 2025 AGM and in accordance with Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

Any purchase of Ordinary Shares pursuant to the Buyback will be announced by no later the end of the 7th daily market session following the calendar day on which such transaction occurred.

The Company will make further announcements in due course following the completion of any repurchases. There is no guarantee that the Buyback will be implemented in full or that any Ordinary Shares will be repurchased by the Company. The Buyback will not impact the Company's existing Ordinary Share dividend policy, which will continue unaffected through the regular awards of interim and final dividends. At the time of this announcement, the Company's share capital comprises 266,714,895 Ordinary Shares with voting rights.

Enquiries:

 

Investors and analysts matt.jones@costain.com

Matt Jones, Costain +44 (0) 7860 922341

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain improves people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. Through the delivery of predictable, best-in-class solutions across the transport, water, energy and defence markets, we are creating a sustainable future and securing a more prosperous, resilient and decarbonised UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBQXLLBBZ
Date   Source Headline
7th Oct 202012:10 pmRNSLong Term Incentive Plan Awards
5th Oct 20207:00 amRNSDirectorate Change
24th Sep 20209:20 amRNSHolding(s) in Company
14th Sep 20207:00 amRNSResults for the half year ended 30 June 2020
9th Sep 20201:08 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSUpdate on the A465 contract
17th Aug 20207:00 amRNSTrading Update and Revised Date of Half Year
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
5th Aug 20202:09 pmRNSHolding(s) in Company
31st Jul 20207:05 amRNSBoard Notification – External Directorship
14th Jul 202010:30 amRNSCostain awarded Cadent contract
1st Jul 20209:15 amRNSBlock listing Interim Return
29th Jun 20207:00 amRNSPeterborough and Huntington Compressor Stations
19th Jun 202011:30 amRNSResult of AGM
19th Jun 20207:00 amRNSAGM trading update
15th Jun 20204:10 pmRNSDirector/PDMR Shareholding
10th Jun 202012:45 pmRNSDirector/PDMR Shareholding
9th Jun 20207:05 amRNSBoard Notification – External Directorship
8th Jun 20207:00 amRNSCostain Appointed onto Strategic Pipeline Alliance
4th Jun 20204:36 pmRNSHolding(s) in Company - Replacement
3rd Jun 20203:35 pmRNSHolding(s) in Company
2nd Jun 20203:38 pmRNSHolding(s) in Company
2nd Jun 20203:31 pmRNSHolding(s) in Company
2nd Jun 202012:07 pmRNSHolding(s) in Company
29th May 202012:00 pmRNSAppointment of non-executive director
29th May 202011:34 amRNSDirector/PDMR Shareholding
28th May 20205:49 pmRNSHolding(s) in Company
28th May 20207:00 amRNSResults of Capital Raising and General Meeting
18th May 20209:05 amRNSNotice of 2020 Annual General Meeting
7th May 20201:20 pmRNSPublication of Prospectus
7th May 202010:42 amRNSCompletion of bookbuild
7th May 20207:00 amRNSProposed £100 million Capital Raising
27th Apr 20207:00 amRNSSmart Motorway Programme Alliance
15th Apr 20207:05 amRNSUpdate on Contracts
2nd Apr 20209:38 amRNSAnnual Report and Accounts
31st Mar 20207:00 amRNSUpdate on COVID-19
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20203:32 pmRNSHolding(s) in Company
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSFully Underwritten Capital Raising of up to £100m
11th Mar 20207:00 amRNSFinal Results
13th Feb 20203:44 pmRNSHolding(s) in Company
6th Feb 20207:05 amRNSDirectorate Change
2nd Jan 202010:00 amRNSBlock listing Six Monthly Return
12th Dec 20197:00 amRNSUpdate on the A465 contract and trading
11th Dec 20191:32 pmRNSCompletion of the Disposal of Alcaidesa Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.